Aurobindo Pharma Ltd.

In News

Aurobindo Pharma Limited (NSE:AUROPHARMA) Released Earnings Last Week And Analysts Lifted Their Price Target To ₹1,466 - simplywall.st

simplywall.st - May 24, 2026

Aurobindo Pharma Ltd (BOM:524804) Q4 2026 Earnings Call Highlights: Record Revenues and ... By GuruFocus - Investing.com Canada

Investing.com Canada - May 22, 2026

US FDA Classifies Aurobindo Pharma Subsidiary Unit as OAI - scanx.trade

scanx.trade - May 24, 2026

Explained - Why Aurobindo Pharma shares are trading with losses of over 5% on Friday - CNBC TV18

CNBC TV18 - May 22, 2026

BDA advises Khandelwal Labs on sale of non-oncology branded generics business to Aurobindo - BDA Partners

BDA Partners - Jan 05, 2026

Aurobindo Pharma Q4 PAT edges up 2 pc at Rs 920.84 cr - Devdiscourse

Devdiscourse - May 21, 2026

Aurobindo Pharma Ltd up for third consecutive session - Business Standard

Business Standard - May 21, 2026

Aurobindo Pharma Ltd stock (INE406A01037): rally to fresh 52-week high draws investor focus - AD HOC NEWS

AD HOC NEWS - May 21, 2026

Buy Aurobindo Pharma Ltd for the Target Rs 1,680 by Motilal Oswal Financial Services Ltd - Investment Guru

Investment Guru - May 25, 2026

Aurobindo Pharma Subsidiary Acquires Khandelwal Laboratories Business - India News Network

India News Network - Jan 02, 2026

Q4 Results Today: Aurobindo Pharma, GAIL, LIC, ITC, Nykaa, Honasa Consumer — Check Estimates - NDTV Profit

NDTV Profit - May 21, 2026

Aurobindo Pharma acquires branded non-oncology prescription business of Khandelwal Labs' for Rs 325 crore - The Times of India

The Times of India - Jan 01, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment